We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$255B
AUM Growth
+$16.4B
Cap. Flow
+$5.08B
Cap. Flow %
1.99%
Top 10 Hldgs %
11.49%
Holding
6,894
New
193
Increased
3,258
Reduced
2,717
Closed
141

Sector Composition

Rank Sector Weight
1 Technology 8.7%
2 Financials 8.5%
3 Healthcare 8.22%
4 Energy 7.4%
5 Communication Services 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNIO
5026
DELISTED
ISHARES TR INDL/OFFICE REAL ESTATE CAPPED ETF
FNIO
$215K ﹤0.01%
6,459
-1,120
-15% -$37.1K
OMF icon
5027
OneMain Financial
OMF
$7.27B
$214K ﹤0.01%
8,225
+1,885
+30% +$46.2K
TBPH icon
5028
Theravance Biopharma
TBPH
$876M
$214K ﹤0.01%
+6,724
New +$202K
JPP
5029
DELISTED
SPDR RUSSELL/NOMURA PRIME JAPAN ETF
JPP
$214K ﹤0.01%
4,626
-32,762
-88% -$1.43M
KYTH
5030
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$214K ﹤0.01%
5,549
-10,601
-66% -$370K
CTIC
5031
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$214K ﹤0.01%
7,618
-45,966
-86% -$1.38M
BFY
5032
DELISTED
BlackRock New York Municipal Income Trust II
BFY
$214K ﹤0.01%
15,228
BCOV
5033
DELISTED
Brightcove, Inc.
BCOV
$213K ﹤0.01%
20,247
-769
-4% -$7.1K
ICMB icon
5034
Investcorp Credit Management BDC
ICMB
$11.9M
$212K ﹤0.01%
14,648
+14,552
+15,158% +$204K
LSTA icon
5035
Lisata Therapeutics
LSTA
$9.82M
$212K ﹤0.01%
217
-154
-42% -$150K
SILC icon
5036
Silicom
SILC
$240M
$212K ﹤0.01%
5,043
-35,809
-88% -$1.76M
AERI
5037
DELISTED
Aerie Pharmaceuticals
AERI
$212K ﹤0.01%
8,532
+3,568
+72% +$61.8K
JO
5038
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
$212K ﹤0.01%
6,305
+329
+6% +$12.1K
ALFA
5039
DELISTED
AlphaClone Alternative Alpha ETF
ALFA
$212K ﹤0.01%
5,411
BSET icon
5040
Bassett Furniture
BSET
$169M
$211K ﹤0.01%
16,054
-15,454
-49% -$209K
CO
5041
DELISTED
Global Cord Blood Corporation
CO
$211K ﹤0.01%
38,269
-4,067
-10% -$18.3K
FRTX
5042
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$210K ﹤0.01%
54
+44
+440% +$166K
MAG
5043
DELISTED
MAG Silver
MAG
$209K ﹤0.01%
22,141
-3,847
-15% -$30.1K
PULM icon
5044
Pulmatrix
PULM
$5.73M
$209K ﹤0.01%
+70
New +$231K
ENTA icon
5045
Enanta Pharmaceuticals
ENTA
$402M
$208K ﹤0.01%
4,829
-390
-7% -$14.9K
QDEL icon
5046
QuidelOrtho
QDEL
$938M
$208K ﹤0.01%
9,441
-1,687
-15% -$38.8K
DDF
5047
DELISTED
Delaware Investments Dividend & Income Fund, Inc.
DDF
$208K ﹤0.01%
19,905
+9,658
+94% +$95.5K
ADRA
5048
DELISTED
Invesco BLDRS Asia 50 ADR Index Fund
ADRA
$208K ﹤0.01%
6,965
+404
+6% +$11.5K
ADRU
5049
DELISTED
Invesco BLDRS Europe Select ADR Index Fund
ADRU
$208K ﹤0.01%
8,118
-76
-0.9% -$1.93K
SMT
5050
DELISTED
SMART TECHNOLOGIES INC COM NEW
SMT
$208K ﹤0.01%
7,291
-2,166
-23% -$74.3K

Similar funds

Morgan Stanley's Q2 2014 Portfolio in Review

As of Q2 2014, Morgan Stanley held 6,894 positions worth $255B, up 6.9% from $239B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 4.8%. Morgan Stanley opened 193 new positions and exited 141, leaving the 6,894-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.5% a quarter earlier, followed by Financials and Healthcare.

  • Morgan Stanley's largest Q2 2014 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 1,258,571 shares worth $89.1M.
  • Morgan Stanley added most to iShares Russell 2000 ETF in Q2 2014, an estimated $839M increase.
  • Morgan Stanley's biggest Q2 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.15B.
  • Morgan Stanley fully exited BRE PROPERTIES INC CL A in Q2 2014, selling an estimated $324M.
  • Morgan Stanley's ten largest holdings make up 11% of its $255B portfolio in Q2 2014.
  • Morgan Stanley opened 193 new positions and closed 141 in Q2 2014.
  • Morgan Stanley's portfolio value rose 6.9% quarter-over-quarter to $255B.

Based on Morgan Stanley's 13F filing for Q2 2014, filed 12 Aug 2014.